These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8082076)
1. The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique. Mourad WA; Setrakian S; Hales ML; Abdulla M; Trucco G Cancer; 1994 Sep; 74(6):1739-45. PubMed ID: 8082076 [TBL] [Abstract][Full Text] [Related]
2. Aneuploidy in sclerosing adenosis may predict an increased risk of malignancy. A study using the AgNOR silver stain. Mourad WA Pathology; 1997 Aug; 29(3):255-9. PubMed ID: 9271010 [TBL] [Abstract][Full Text] [Related]
3. Predictors of invasion in ductal carcinoma in Situ of the breast: The value of a scoring system. Mourad WA; Devloo S; Setrakian S Ann Saudi Med; 1997 Jul; 17(4):427-31. PubMed ID: 17353595 [TBL] [Abstract][Full Text] [Related]
4. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status. Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892 [TBL] [Abstract][Full Text] [Related]
5. Two AgNOR counts in fine-needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry. Mourad WA; Katz RL; Sembera D; Atkinson EN; el-Naggar AK Diagn Cytopathol; 1992; 8(2):128-34. PubMed ID: 1568410 [TBL] [Abstract][Full Text] [Related]
6. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast. Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036 [TBL] [Abstract][Full Text] [Related]
7. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma. Mourad WA; Sneige N; Katz RL; Ordóñez NG Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588 [TBL] [Abstract][Full Text] [Related]
8. Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component. Brower ST; Ahmed S; Tartter PI; Bleiweiss I; Amberson JB Ann Surg Oncol; 1995 Sep; 2(5):440-4. PubMed ID: 7496840 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses. Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214 [TBL] [Abstract][Full Text] [Related]
10. Cell kinetic analysis of interleukin-2 receptor-tested chronic lymphocytic leukemia using the AgNOR silver stain. Mourad WA; Pugh WC; Huh YO; Keating MJ Am J Clin Pathol; 1994 Mar; 101(3):300-4. PubMed ID: 8135185 [TBL] [Abstract][Full Text] [Related]
11. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998 [TBL] [Abstract][Full Text] [Related]
12. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain. Mourad WA; Connelly JH; Sembera DL; Atkinson EN; Bruner JM Hum Pathol; 1993 Feb; 24(2):206-10. PubMed ID: 8432516 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Simpson JF; O'Malley F; Dupont WD; Page DL Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249 [TBL] [Abstract][Full Text] [Related]
14. Cell kinetics analysis of surgically resected non-small cell carcinoma of the lung using the AgNOR silver stain. Mourad WA; Vallieres E; Chuen J; Alrobaish A Ann Saudi Med; 1997 Mar; 17(2):161-6. PubMed ID: 17377422 [TBL] [Abstract][Full Text] [Related]
15. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry. Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Xie X; Clausen OP; Sudbö J; Boysen M Cancer; 1997 Jun; 79(11):2200-8. PubMed ID: 9179068 [TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar organizer regions (AgNORs) in breast lesions--a study on fine needle aspirates. Karmakar T; Radhika S; Gupta SK Cytopathology; 1995 Feb; 6(1):5-13. PubMed ID: 7734703 [TBL] [Abstract][Full Text] [Related]
18. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
20. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast. Susnik B; Worth A; Palcic B; Poulin N; LeRiche J Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]